$BJDX
Bluejay Diagnostics, Inc.

2022 Q3 Form 10-Q Financial Statement

#000121390022046314 Filed on August 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $249.0K $0.00
YoY Change
Cost Of Revenue $200.1K
YoY Change
Gross Profit $48.91K
YoY Change
Gross Profit Margin 19.64%
Selling, General & Admin $1.431M $1.278M $1.374M
YoY Change 177.52% 190.48%
% of Gross Profit 2613.63%
Research & Development $1.380M $756.3K $694.8K
YoY Change 211.77% 234.65%
% of Gross Profit 1546.24%
Depreciation & Amortization $42.13K $43.82K $39.97K
YoY Change 0.29% -32.06%
% of Gross Profit 89.59%
Operating Expenses $2.810M $2.035M $2.068M
YoY Change 193.34% 205.47%
Operating Profit -$2.810M -$1.986M -$2.068M
YoY Change 193.34% 198.12%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net -$149.7K $48.32K $54.86K
YoY Change -7438.77% 87.02%
Pretax Income -$2.960M -$1.937M -$2.013M
YoY Change 148.03% 132.19%
Income Tax
% Of Pretax Income
Net Earnings -$2.960M -$1.937M -$2.013M
YoY Change 148.03% 202.61% 936.83%
Net Earnings / Revenue -777.95%
Basic Earnings Per Share -$0.15 -$0.10 -$0.10
Diluted Earnings Per Share -$0.15 -$0.10 -$99.96K
COMMON SHARES
Basic Shares Outstanding 20.15M shares 20.15M shares 20.14M shares
Diluted Shares Outstanding 20.15M shares 20.15M shares 20.14M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.29M $15.34M $17.12M
YoY Change 470.32% 539.12%
Cash & Equivalents $13.29M $15.34M $17.12M
Short-Term Investments
Other Short-Term Assets $646.9K $1.037M $1.303M
YoY Change -30.72% 212.03%
Inventory $671.3K $893.2K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $13.94M $17.05M $19.32M
YoY Change 326.99% 523.9%
LONG-TERM ASSETS
Property, Plant & Equipment $1.238M $409.1K $740.4K
YoY Change 245.09% 4.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $33.48K $35.08K $20.23K
YoY Change
Total Long-Term Assets $1.769M $1.017M $760.7K
YoY Change 393.09% 159.02%
TOTAL ASSETS
Total Short-Term Assets $13.94M $17.05M $19.32M
Total Long-Term Assets $1.769M $1.017M $760.7K
Total Assets $15.71M $18.07M $20.08M
YoY Change 333.54% 478.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $443.0K $196.1K $716.8K
YoY Change 82.42% -36.61%
Accrued Expenses $1.080M $783.5K $592.6K
YoY Change 190.79% 270.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $4.520K
YoY Change
Total Short-Term Liabilities $1.523M $979.6K $1.309M
YoY Change -67.63% -69.85%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $15.42K $430.1K $282.3K
YoY Change
Total Long-Term Liabilities $15.42K $430.1K $282.3K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.523M $979.6K $1.309M
Total Long-Term Liabilities $15.42K $430.1K $282.3K
Total Liabilities $1.895M $1.410M $1.592M
YoY Change -59.72% -56.61%
SHAREHOLDERS EQUITY
Retained Earnings -$14.61M -$11.65M
YoY Change
Common Stock $2.015K $2.015K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.81M $16.66M $18.49M
YoY Change
Total Liabilities & Shareholders Equity $15.71M $18.07M $20.08M
YoY Change 333.54% 478.06%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$2.960M -$1.937M -$2.013M
YoY Change 148.03% 202.61% 936.83%
Depreciation, Depletion And Amortization $42.13K $43.82K $39.97K
YoY Change 0.29% -32.06%
Cash From Operating Activities -$1.261M -$1.659M -$1.877M
YoY Change 13.5% 126.44%
INVESTING ACTIVITIES
Capital Expenditures -$791.5K -$123.3K -$46.35K
YoY Change 12644.93%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$791.5K -$123.3K -$46.35K
YoY Change 9623.1% -6486.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -1.261M -1.659M -1.877M
Cash From Investing Activities -791.5K -123.3K -46.35K
Cash From Financing Activities 0.000 0.000
Net Change In Cash -2.052M -1.782M $0.00
YoY Change 2819.2% -219.77%
FREE CASH FLOW
Cash From Operating Activities -$1.261M -$1.659M -$1.877M
Capital Expenditures -$791.5K -$123.3K -$46.35K
Free Cash Flow -$469.6K -$1.536M -$1.831M
YoY Change -57.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41031
dei Entity Registrant Name
EntityRegistrantName
Bluejay Diagnostics, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3552922
dei Entity Address Address Line1
EntityAddressAddressLine1
360 Massachusetts Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 203
dei Entity Address City Or Town
EntityAddressCityOrTown
Acton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01720
dei City Area Code
CityAreaCode
(844)
dei Local Phone Number
LocalPhoneNumber
327-7078
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
BJDX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20152344 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15341862 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19047778 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
671250 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1037145 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1612708 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
17050257 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
20660486 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
409070 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
337366 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
573040 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35075 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21019 usd
CY2022Q2 us-gaap Assets
Assets
18067442 usd
CY2021Q4 us-gaap Assets
Assets
21018871 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
196108 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
295778 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
783482 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
341384 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
979590 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
637162 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
430116 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1409706 usd
CY2021Q4 us-gaap Liabilities
Liabilities
637162 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20152344 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20152344 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20112244 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20112244 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
2015 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2011 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28306680 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28074484 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11650959 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7694786 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
16657736 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20381709 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18067442 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21018871 usd
CY2022Q2 us-gaap Revenues
Revenues
249040 usd
us-gaap Revenues
Revenues
249040 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
200129 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
200129 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
48911 usd
us-gaap Gross Profit
GrossProfit
48911 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
756283 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
225992 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1451040 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
250175 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1196996 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
389830 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2516815 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
529741 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
81357 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
50250 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
135042 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
119354 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2034636 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
666072 usd
us-gaap Operating Expenses
OperatingExpenses
4102897 usd
us-gaap Operating Expenses
OperatingExpenses
899270 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1985725 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-666072 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4053986 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-899270 usd
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-59167 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-32116 usd
CY2021Q2 bjdx State Grant Income
StateGrantIncome
75000 usd
bjdx State Grant Income
StateGrantIncome
75000 usd
CY2022Q2 us-gaap Other Income
OtherIncome
48323 usd
CY2021Q2 us-gaap Other Income
OtherIncome
10006 usd
us-gaap Other Income
OtherIncome
103181 usd
us-gaap Other Income
OtherIncome
21965 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
48323 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25839 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
103181 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
64849 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1937402 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-640233 usd
us-gaap Net Income Loss
NetIncomeLoss
-3950805 usd
us-gaap Net Income Loss
NetIncomeLoss
-834421 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20151969 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4201688 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20147161 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4201688 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20381709 usd
CY2022Q1 bjdx Cumulative Effect Period Of Adoption Adjusted Balance
CumulativeEffectPeriodOfAdoptionAdjustedBalance
-5368 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
126086 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2013403 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
18489024 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
106114 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1937402 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
16657736 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-4206173 usd
CY2021Q1 bjdx Accretion Of Series Redeemable Convertible Preferred Stock Dividend
AccretionOfSeriesRedeemableConvertiblePreferredStockDividend
-76720 usd
CY2021Q1 bjdx Stockbased Compensation Benefit
StockbasedCompensationBenefit
164 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
180339 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-640233 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-194188 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-4296578 usd
CY2021Q2 bjdx Accretion Of Series Redeemable Convertible Preferred Stock Dividend
AccretionOfSeriesRedeemableConvertiblePreferredStockDividend
-51147 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-123485 usd
us-gaap Net Income Loss
NetIncomeLoss
-3950805 usd
us-gaap Net Income Loss
NetIncomeLoss
-834421 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
83792 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
68372 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
232200 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
319 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
66972 usd
CY2021Q2 bjdx Stockbased Compensation Benefit
StockbasedCompensationBenefit
155 usd
CY2021Q2 bjdx Conversion Of Redeemable Convertible Preferred Stock Into Common Stock
ConversionOfRedeemableConvertiblePreferredStockIntoCommonStock
4005982 usd
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
132383 usd
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
580000 usd
CY2021Q2 bjdx Reclassification Of Warrants To Equity
ReclassificationOfWarrantsToEquity
145953 usd
bjdx Debt Instrument Decrease Forgivenes
DebtInstrumentDecreaseForgivenes
-5000 usd
bjdx Amortization Of Debt Discount Premiums
AmortizationOfDebtDiscountPremiums
1770 usd
bjdx Gain Loss On Revaluation Of Derivative Warrant Liability
GainLossOnRevaluationOfDerivativeWarrantLiability
-9676 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
671250 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-84762 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-575563 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
3425 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
14056 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-99670 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-98388 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
2000 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
10000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
242937 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
76886 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3536317 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-728801 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
169599 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1934 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-169599 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1934 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
87552 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
289617 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
395000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3000000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-9000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2218831 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3705916 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1488096 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19047778 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
912361 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15341862 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2400457 usd
us-gaap Interest Paid Net
InterestPaidNet
25328 usd
bjdx Exercise Of Warrants Through Debt Principal Conversion
ExerciseOfWarrantsThroughDebtPrincipalConversion
132383 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
4005982 usd
bjdx Conversion Of Amended2017 Convertible Notes
ConversionOfAmended2017ConvertibleNotes
580000 usd
bjdx Reclassification Of Derivative Warrant Liability Into Additional Paidin Capital
ReclassificationOfDerivativeWarrantLiabilityIntoAdditionalPaidinCapital
145953 usd
bjdx Fair Value Of Warrants Issued To Underwriters
FairValueOfWarrantsIssuedToUnderwriters
180339 usd
bjdx Unrestricted Cash And Cash Equivalents
UnrestrictedCashAndCashEquivalents
15300000 usd
CY2021Q2 us-gaap Shares Issued
SharesIssued
2.15 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. The Company believes judgment is involved in accounting for the fair value-based measurement of stock-based compensation, accruals, convertible notes and warrants. The Company evaluates its estimates and assumptions as facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from these estimates and assumptions, and those differences could be material to the condensed consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y4M24D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
133968 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.45
bjdx Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
3000000 usd
bjdx Option To Purchase Common Stock
OptionToPurchaseCommonStock
805805 usd
bjdx Option To Purchase Common Stock
OptionToPurchaseCommonStock
375826 usd
bjdx Warrants For Common Stock
WarrantsForCommonStock
811882 usd
bjdx Warrants For Common Stock
WarrantsForCommonStock
1022120 usd
CY2022Q2 bjdx Class A Warrants For Common Stockin Shares
ClassAWarrantsForCommonStockinShares
2484000 usd
CY2022Q2 bjdx Class B Warrants For Common Stockin Shares
ClassBWarrantsForCommonStockinShares
75400 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
601647 usd
CY2022Q1 bjdx Right Of Use Assets And Lease Liabilities
RightOfUseAssetsAndLeaseLiabilities
200000 usd
CY2020Q4 bjdx Royalty Percentage
RoyaltyPercentage
0.15 pure
CY2020Q4 bjdx Sale Term
SaleTerm
P5Y
CY2020Q4 bjdx Royalty In Each Year Thereafter
RoyaltyInEachYearThereafter
100000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
71421 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
usd
bjdx Class B Warrant Rights Description
ClassBWarrantRightsDescription
Holders of Class B Warrants may also exercise such warrants on a “cashless” basis after the earlier of (i) 10 trading days from closing date of the offering or (ii) the time when $10 million of volume is traded in our common stock, if the volume weighted average price of the Company’s common stock on any trading day on or after the closing date of the offering fails to exceed the exercise price of the Class B Warrant (subject to adjustment as described in the warrant agreement). In such event, the aggregate number of shares of common stock issuable in such cashless exercise shall equal the product of (x) the aggregate number of shares of common stock that would be issuable upon exercise of the Class B Warrant in accordance with its terms if such exercise were by means of a cash exercise rather than a cashless exercise and (y) 1.00.
bjdx Warrants Exercised
WarrantsExercised
1100 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
262269 shares
CY2021Q3 bjdx Common Stock Capital Shares Reserved For Issuance
CommonStockCapitalSharesReservedForIssuance
1960000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
105000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.29
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
105000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.29
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
589786 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.86
bjdx Weighted Average Remaining Contractual Life In Years Outstanding At Begining Balance
WeightedAverageRemainingContractualLifeInYearsOutstandingAtBeginingBalance
P8Y3M18D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
605187 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
226279 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.84
us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
10260 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.68
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
805805 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.84
bjdx Weighted Average Remaining Contractual Life In Years Outstanding At Ending Balance
WeightedAverageRemainingContractualLifeInYearsOutstandingAtEndingBalance
P8Y3M18D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
140248 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
393312 shares
bjdx Share Based Compensation Arrangements By Share Based Payment Award Options Exercisable In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageExercisePrice
1.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.886 pure
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
106114 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
155 usd
us-gaap Share Based Compensation
ShareBasedCompensation
232200 usd
us-gaap Share Based Compensation
ShareBasedCompensation
319 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
130392 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
bjdx Stock Issued During Period Shares Stock Option Exercised
StockIssuedDuringPeriodSharesStockOptionExercised
shares
CY2021Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
573040 usd
CY2022Q2 bjdx Operating Lease Right Of Use Assets
OperatingLeaseRightOfUseAssets
573040 usd
bjdx Employees Cost Plus Percentage
EmployeesCostPlusPercentage
0.10 pure
bjdx Schedule Of Amounts Earned And Due
ScheduleOfAmountsEarnedAndDue
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended <br/> June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended <br/> June 30,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Income from NanoHybrids included in Other Income</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">35,040</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">-</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">75,926</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-109">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr> <td style="text-align: left">Cash receipts from NanoHybrids</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">18,347</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">40,886</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-111">-</span></td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Amounts receivable from NanoHybrids included in Prepaids and Other Current Assets</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">35,040</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="width: 1%; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
35040 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
75926 usd
CY2022Q2 bjdx Cash Received From Related Party
CashReceivedFromRelatedParty
18347 usd
bjdx Cash Received From Related Party
CashReceivedFromRelatedParty
40886 usd
CY2022Q2 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
35040 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
171531 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
430116 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
601647 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
941699 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
786203 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
532629 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
448837 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
409070 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
337366 usd
CY2021Q2 bjdx Cash Received From Related Party
CashReceivedFromRelatedParty
usd
bjdx Cash Received From Related Party
CashReceivedFromRelatedParty
usd
CY2021Q4 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
usd
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2022Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.07 pure
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
164620 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
160804 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
100000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
100000 usd
CY2022Q2 bjdx Lessor Operating Lease Paymentstobe Received Thereafter
LessorOperatingLeasePaymentstobeReceivedThereafter
25000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
643813 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
42166 usd
CY2022Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
600000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
usd
CY2022Q2 bjdx State Grant Income
StateGrantIncome
usd
bjdx State Grant Income
StateGrantIncome
usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4201688 shares
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
usd
bjdx Debt Instrument Decrease Forgivenes
DebtInstrumentDecreaseForgivenes
usd
bjdx Amortization Of Debt Discount Premiums
AmortizationOfDebtDiscountPremiums
usd
bjdx Gain Loss On Revaluation Of Derivative Warrant Liability
GainLossOnRevaluationOfDerivativeWarrantLiability
usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
bjdx Exercise Of Warrants Through Debt Principal Conversion
ExerciseOfWarrantsThroughDebtPrincipalConversion
usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
bjdx Conversion Of Amended2017 Convertible Notes
ConversionOfAmended2017ConvertibleNotes
usd
bjdx Reclassification Of Derivative Warrant Liability Into Additional Paidin Capital
ReclassificationOfDerivativeWarrantLiabilityIntoAdditionalPaidinCapital
usd
bjdx Fair Value Of Warrants Issued To Underwriters
FairValueOfWarrantsIssuedToUnderwriters
usd
bjdx Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
usd
CY2021Q2 bjdx Class A Warrants For Common Stockin Shares
ClassAWarrantsForCommonStockinShares
usd
CY2021Q2 bjdx Class B Warrants For Common Stockin Shares
ClassBWarrantsForCommonStockinShares
usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
dei Entity Central Index Key
EntityCentralIndexKey
0001704287
CY2021Q2 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
usd

Files In Submission

Name View Source Status
bjdx-20220630_pre.xml Edgar Link unprocessable
0001213900-22-046314-index-headers.html Edgar Link pending
0001213900-22-046314-index.html Edgar Link pending
0001213900-22-046314.txt Edgar Link pending
0001213900-22-046314-xbrl.zip Edgar Link pending
bjdx-20220630.xsd Edgar Link pending
bjdx-20220630_cal.xml Edgar Link unprocessable
bjdx-20220630_def.xml Edgar Link unprocessable
bjdx-20220630_lab.xml Edgar Link unprocessable
f10q0622ex31-1_bluejay.htm Edgar Link pending
f10q0622ex31-2_bluejay.htm Edgar Link pending
f10q0622ex32-1_bluejay.htm Edgar Link pending
f10q0622ex32-2_bluejay.htm Edgar Link pending
f10q0622_bluejay.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10q0622_bluejay_htm.xml Edgar Link completed